Establishment Labs Holdings Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
Establishment Labs Holdings Inc. (ESTA) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2025-02-28
- Establishment Labs Holdings Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-12-31 was $0.00.
- Establishment Labs Holdings Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-09-30 was $0.00.
- Establishment Labs Holdings Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Establishment Labs Holdings Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-03-31 was $0.00.
- Establishment Labs Holdings Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2024 was $0.00.
- Establishment Labs Holdings Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Establishment Labs Holdings Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2022 was $703.00K, a 4.61% decline from fiscal 2021.
- Establishment Labs Holdings Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2021 was $737.00K, a 54.84% decline from fiscal 2020.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $1.10M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $1.10M derived: sum of 3 quarters · filed 2025-02-28 | $703.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $1.10M derived: sum of 2 quarters · filed 2023-11-08 | $703.00K 10-Q · filed 2023-11-08 | $894.00K derived: sum of 4 quarters · filed 2024-03-04 |
| 2022-06-30 | $1.10M 10-Q · filed 2023-08-09 | $703.00K 10-Q · filed 2023-08-09 | $894.00K derived: sum of 3 quarters · filed 2024-03-04 | $951.00K derived: sum of 4 quarters · filed 2024-03-04 |
| 2022-03-31 | -$396.00K 10-Q · filed 2023-05-10 | -$205.00K derived: sum of 2 quarters · filed 2024-03-04 | -$148.00K derived: sum of 3 quarters · filed 2024-03-04 | $111.00K derived: sum of 4 quarters · filed 2024-03-04 |
| 2021-12-31 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $248.00K derived: sum of 2 quarters · filed 2024-03-04 | $507.00K derived: sum of 3 quarters · filed 2024-03-04 | $737.00K 10-K · filed 2024-03-04 |
| 2021-09-30 | $57.00K 10-Q · filed 2022-11-09 | $316.00K derived: sum of 2 quarters · filed 2022-11-09 | $546.00K 10-Q · filed 2022-11-09 | $1.74M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $259.00K 10-Q · filed 2022-08-09 | $489.00K 10-Q · filed 2022-08-09 | $1.68M derived: sum of 3 quarters · filed 2023-03-01 | $2.56M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $230.00K 10-Q · filed 2022-05-10 | $1.42M derived: sum of 2 quarters · filed 2023-03-01 | $2.30M derived: sum of 3 quarters · filed 2023-03-01 | $3.79M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.07M derived: sum of 2 quarters · filed 2023-03-01 | $3.56M derived: sum of 3 quarters · filed 2023-03-01 | $1.63M 10-K · filed 2023-03-01 |
| 2020-09-30 | $879.00K 10-Q · filed 2021-11-09 | $2.37M derived: sum of 2 quarters · filed 2021-11-09 | $442.00K 10-Q · filed 2021-11-09 | $651.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $1.49M 10-Q · filed 2021-07-30 | -$437.00K 10-Q · filed 2021-07-30 | -$228.00K derived: sum of 3 quarters · filed 2022-03-01 | $7.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$1.93M 10-Q · filed 2021-05-06 | -$1.72M derived: sum of 2 quarters · filed 2022-03-01 | -$1.49M derived: sum of 3 quarters · filed 2022-03-01 | $1.16M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $444.00K derived: sum of 2 quarters · filed 2022-03-01 | $3.08M derived: sum of 3 quarters · filed 2022-03-01 | $3.05M 10-K · filed 2022-03-01 |
| 2019-09-30 | $235.00K 10-Q · filed 2020-11-09 | $2.88M derived: sum of 2 quarters · filed 2020-11-09 | $2.84M 10-Q · filed 2020-11-09 | $2.79M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $2.64M 10-Q · filed 2020-08-07 | $2.61M 10-Q · filed 2020-08-07 | $2.56M derived: sum of 3 quarters · filed 2020-08-07 | $13.98M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | -$32.00K 10-Q · filed 2020-05-08 | -$83.00K derived: sum of 2 quarters · filed 2020-05-08 | $11.34M derived: sum of 3 quarters · filed 2020-05-08 | $17.17M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $11.37M derived: sum of 2 quarters · filed 2020-03-16 | $17.20M derived: sum of 3 quarters · filed 2020-03-16 | $15.89M 10-K · filed 2020-03-16 |
| 2018-09-30 | $11.42M 10-Q · filed 2019-11-12 | $17.25M derived: sum of 2 quarters · filed 2019-11-12 | $15.95M 10-Q · filed 2019-11-12 | $15.62M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $5.83M 10-Q · filed 2019-08-13 | $4.53M 10-Q · filed 2019-08-13 | $4.20M derived: sum of 3 quarters · filed 2019-08-13 | $6.30M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | -$1.30M 10-Q · filed 2019-05-15 | -$1.63M derived: sum of 2 quarters · filed 2019-05-15 | $466.00K derived: sum of 3 quarters · filed 2019-05-15 | -$3.45M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | $1.77M derived: sum of 2 quarters · filed 2019-03-20 | -$2.14M derived: sum of 3 quarters · filed 2019-03-20 | -$2.43M 10-K · filed 2019-03-20 |
| 2017-09-30 | $2.10M 10-Q · filed 2018-11-13 | -$1.82M derived: sum of 2 quarters · filed 2018-11-13 | -$2.10M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | -$3.91M 10-Q · filed 2018-09-13 | -$4.20M 10-Q · filed 2018-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |